Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Major histocompatibility complex, t-complex, and leukemia.

M T Dorak1, A K Burnett

  • 1Department of Haematology, Glasgow Royal Infirmary, UK.

Cancer Causes & Control : CCC
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial.

Leukemia·2018
Same author

What has GWAS done for HLA and disease associations?

International journal of immunogenetics·2017
Same author

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Leukemia·2017
Same author

Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia.

Leukemia·2017
Same author

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia.

Leukemia·2016
Same author

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia.

Leukemia·2016

Leukemia

Area of Science:

  • Genetics and immunology
  • Cancer research

Background:

  • Leukemia has known associations with major histocompatibility complex (MHC) genes.
  • Atypical human leukocyte antigen (HLA) segregation patterns in leukemic families suggest complex genetic influences beyond simple allelic associations.

Purpose of the Study:

  • To explore genetic factors influencing leukemia susceptibility and transmission patterns.
  • To investigate the role of MHC-linked regions and segregation distortion in leukemogenesis.

Main Methods:

  • Analysis of HLA segregation patterns in leukemic families.
  • Comparison with genetic models like the mouse t-complex and rat growth and reproduction complex (grc).

Main Results:

  • Observed increased HLA homozygosity, maternal HLA-DR identity, and preferential transmission of certain haplotypes in leukemic families.

Related Experiment Videos

  • The mouse t-complex model, with its recessive lethal genes and paternal transmission bias, aligns with observed segregation distortions.

    • Conclusions:

    • The human leukocyte antigen (HLA) system may not be directly involved in leukemogenesis, but linked genetic regions could cause segregation distortion.
    • A model involving MHC-linked recessive susceptibility genes, similar to the mouse t-complex, could explain observed familial leukemia patterns and associated phenomena.